相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An ADAM12 and FAK positive feedback loop amplifies the interaction signal of tumor cells with extracellular matrix to promote esophageal cancer metastasis
Man-Li Luo et al.
CANCER LETTERS (2018)
ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins
Byung-Chul Jeong et al.
BONE (2017)
Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas
Junwen Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
First-trimester maternal serum ADAM12-s and PAPP-A levels are altered in pregnancies conceived after assisted reproduction techniques (ART)
Maarit Sahraravand et al.
PRENATAL DIAGNOSIS (2016)
The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis
Bo Tian et al.
BIOMATERIALS (2014)
Mitogen- and stress-activated protein kinase 1 activates osteoclastogenesis in vitro and affects bone destruction in vivo
Jeongim Ha et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Vitamin E decreases bone mass by stimulating osteoclast fusion
Koji Fujita et al.
NATURE MEDICINE (2012)
Maslinic Acid Suppresses Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss by Regulating RANKL-Mediated NF-κB and MAPK Signaling Pathways
Chenghai Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Discovery of 6-(2,4-Difluorophenoxy)-2[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (Pamapimod) and 6-(2,4-Difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as Orally Bioavailable and Highly Selective Inhibitors of p38α Mitogen-Activated Protein Kinase
David M. Goldstein et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Osteoporosis: burden, health care provision and opportunities in the EU
O. Ström et al.
Archives of Osteoporosis (2011)
Evaluation of the Efficacy and Safety of Pamapimod, a p38 MAP Kinase Inhibitor, in a Double-Blind, Methotrexate-Controlled Study of Patients With Active Rheumatoid Arthritis
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2009)
The α-Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss
Christina Boehm et al.
JOURNAL OF IMMUNOLOGY (2009)
Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity
Ronald J. Hill et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation
Sudarshana M. Sharma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway
Hao Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of osteoclast differentiation and function by the CaMK-CREB pathway
Kojiro Sato et al.
NATURE MEDICINE (2006)
The many paths to p38 mitogen-activated protein kinase activation in the immune system
Jonathan D. Ashwell
NATURE REVIEWS IMMUNOLOGY (2006)
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors
A Bamias et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Predictive value of BMD for hip and other fractures
O Johnell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Phosphorylation of c-fos by members of the p38 MAPK family - Role in the AP-1 response to UV light
T Tanos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ADAM gene expression and regulation during human osteoclast formation
S Verrier et al.
BONE (2004)
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
K Matsuo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases
S Kumar et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival
A Gingery et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts
H Takayanagi et al.
DEVELOPMENTAL CELL (2002)
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
M Asakura et al.
NATURE MEDICINE (2002)
分享论文
